Phase I Study of AMA1-C1/Alhydrogel® (Registered Trademark) + CPG 7909 Malaria Vaccine
Clinical trial NCT00427167 · COMPLETED
Trial details
- NCT number
- NCT00427167
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-23
- Primary completion
- 2008-11-05
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.